跳至主要内容
临床试验/NCT05299502
NCT05299502进行中(未招募)不适用

Promoting Healthy Eating in Early Pregnancy in Women at Risk of Gestational Diabetes Mellitus: Does it Improve Glucose Homeostasis?

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
150
试验地点
1
主要终点
Fasting plasma glucose

研究概览

简要总结

Healthy eating during pregnancy has favorable effects on markers related to diabetes (glucose tolerance) and is associated with lower gestational diabetes mellitus (GDM) risk. The cornerstone of GDM treatment is nutrition therapy but the latter often starts late in pregnancy and thus may not have the expected effects on glucose tolerance. What if an intervention promoting healthy eating was initiated at the beginning of pregnancy in all women at risk, would it improve glucose homeostasis? To answer this important question, the investigators will perform a randomized controlled trial in 150 pregnant women. Women receiving the nutritional intervention will be compared to a control group receiving standard care. The nutritional intervention, which will start in the first trimester, is based on the 2019 Canada's Food Guide and is composed of 4 individual sessions with a registered dietitian (12, 18, 24 and 30 weeks). Between those follow-ups, informative nutritional web capsules and phone calls with the registered dietitian will be provided. To ensure that the women remain motivated and receive social support, a private Facebook group will be used. The investigators hypothesize that the nutritional intervention will be effective at improving glucose homeostasis. The investigators expect the results will show the importance of nutritional care starting early in pregnancy in women at risk of GDM.

详细描述

Individuals will participate in three on-site research visits during which a 2-hour oral glucose tolerance test will be performed. At each of these trimesters and 3 months after the delivery, participants will also complete three validated web-based 24-h recalls from which diet quality will be assessed. Subjects will be randomized to two arms after the first oral glucose tolerance test at the first visit. For all participants, on-site follow-ups by the research team will occur at each trimester and 1 virtual follow-up will be done 3 months after delivery for both groups. The total duration of participation for all is approximately 9 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •≤ 14 gestational weeks;
  • •Singleton pregnancy;
  • •At risk of GDM According to Diabetes Canada (being 35 years of age or older or from a high-risk group (African, Arab, Asian, Hispanic, Indigenous, or South Asian) or having a BMI ≥ 30 kg/m2, prediabetes, GDM in a previous pregnancy, given birth to a baby that weighed more than 4 kg, a parent, brother or sister with type 2 diabetes, polycystic ovary syndrome or acanthosis nigricans (darkened patches of skin).

排除标准

  • •Having a diabetes diagnosis in the 1st trimester;
  • •Pre-existing diabetes mellitus;
  • •Diseases requiring active nutritional treatment or influencing glucose metabolism (including previous bariatric surgery);
  • •Taking part in a nutritional intervention program;
  • •Corticosteroid use;
  • •Previous or current diagnosis of an eating disorder;
  • •Inability to give informed consent;
  • •Inability to communicate in French.

研究组 & 干预措施

Nutritional Intervention

Experimental

Intervention promoting healthy eating by a Registered Dietitian.

干预措施: Nutritional Intervention (Behavioral)

Standard Care

No Intervention

Women will have their usual medical pregnancy follow-ups by their MDs without access to nutritional care.

结局指标

主要结局

Fasting plasma glucose

时间窗: Changes from the 1st to the 3rd trimester

Measured after a 12-hour fast.

次要结局

  • Hepatic insulin sensitivity(Changes from the 1st to the 3rd trimester)
  • Gestational Diabetes Mellitus diagnosis(End of pregnancy)
  • Post-prandial plasma glucose(Changes from the 1st to the 3rd trimester)
  • Glycemic response(Changes from the 1st to the 3rd trimester)
  • Hepatic and peripheral insulin sensitivity index(Changes from the 1st to the 3rd trimester)
  • Beta-cell function index(Changes from the 1st to the 3rd trimester)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne-Sophie Morisset

Principal Investigator

CHU de Quebec-Universite Laval

研究点 (1)

Loading locations...

相似试验